Melissa Langer

525 total citations
10 papers, 408 citations indexed

About

Melissa Langer is a scholar working on Pulmonary and Respiratory Medicine, Immunology and Oncology. According to data from OpenAlex, Melissa Langer has authored 10 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 3 papers in Immunology and 2 papers in Oncology. Recurrent topics in Melissa Langer's work include Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers), Advanced Breast Cancer Therapies (2 papers) and HER2/EGFR in Cancer Research (2 papers). Melissa Langer is often cited by papers focused on Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers), Advanced Breast Cancer Therapies (2 papers) and HER2/EGFR in Cancer Research (2 papers). Melissa Langer collaborates with scholars based in Germany, United States and Austria. Melissa Langer's co-authors include Michael D. Feldman, Christopher Colameco, Angela DeMichele, Susan M. Domchek, Daniel F. Heitjan, Kristi Gramlich, Maryann Gallagher, Keerthi Gogineni, Noah Goodman and Paul J. Zhang and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and The FASEB Journal.

In The Last Decade

Melissa Langer

10 papers receiving 400 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Melissa Langer Germany 9 287 284 79 72 51 10 408
Yelena Novik United States 11 314 1.1× 150 0.5× 79 1.0× 43 0.6× 129 2.5× 45 536
David Luo United States 9 217 0.8× 252 0.9× 83 1.1× 31 0.4× 185 3.6× 16 431
Elaine Wiegert United States 7 76 0.3× 131 0.5× 59 0.7× 40 0.6× 64 1.3× 9 313
Connie W. C. Hui Hong Kong 11 129 0.4× 154 0.5× 63 0.8× 19 0.3× 157 3.1× 21 389
Ryan Geschwindt United States 10 80 0.3× 137 0.5× 37 0.5× 17 0.2× 94 1.8× 15 337
Yuto Yasuda Japan 10 221 0.8× 172 0.6× 62 0.8× 13 0.2× 121 2.4× 35 346
Ben George United States 6 117 0.4× 131 0.5× 89 1.1× 20 0.3× 220 4.3× 13 473
Claus von Weyhern Germany 9 158 0.6× 192 0.7× 29 0.4× 9 0.1× 107 2.1× 14 429
Liisa Chang United Kingdom 4 183 0.6× 107 0.4× 95 1.2× 9 0.1× 100 2.0× 5 332
Carolien Boeckx Belgium 12 225 0.8× 109 0.4× 99 1.3× 11 0.2× 155 3.0× 15 374

Countries citing papers authored by Melissa Langer

Since Specialization
Citations

This map shows the geographic impact of Melissa Langer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melissa Langer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melissa Langer more than expected).

Fields of papers citing papers by Melissa Langer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melissa Langer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melissa Langer. The network helps show where Melissa Langer may publish in the future.

Co-authorship network of co-authors of Melissa Langer

This figure shows the co-authorship network connecting the top 25 collaborators of Melissa Langer. A scholar is included among the top collaborators of Melissa Langer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melissa Langer. Melissa Langer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Henneck, Timo, Christina Krüger, Andreas Nerlich, et al.. (2023). Comparison of NET quantification methods based on immunofluorescence microscopy: Hand-counting, semi-automated and automated evaluations. Heliyon. 9(6). e16982–e16982. 8 indexed citations
2.
Singh, Rajendra, et al.. (2020). Emerging Approaches for Fluorescence-Based Newborn Screening of Mucopolysaccharidoses. Diagnostics. 10(5). 294–294. 10 indexed citations
3.
Pirr, Sabine, Beate Fehlhaber, Stephan Halle, et al.. (2019). Constitutive TNF‐α signaling in neonates is essential for the development of tissue‐resident leukocyte profiles at barrier sites. The FASEB Journal. 33(10). 10633–10647. 8 indexed citations
4.
Langer, Melissa, et al.. (2018). Comparison Between K3EDTA and Lithium Heparin as Anticoagulant to Isolate Bovine Granulocytes From Blood. Frontiers in Immunology. 9. 1570–1570. 12 indexed citations
5.
Langer, Melissa, Andrea T. Feßler, Nicole de Buhr, et al.. (2017). Testing cathelicidin susceptibility of bacterial mastitis isolates: Technical challenges and data output for clinical isolates. Veterinary Microbiology. 210. 107–115. 9 indexed citations
6.
Maxwell, Kara N., Emin Tahirović, Andrea B. Troxel, et al.. (2017). Comparative clinical utility of tumor genomic testing and cell-free DNA in metastatic breast cancer. Breast Cancer Research and Treatment. 164(3). 627–638. 19 indexed citations
7.
Langer, Melissa, et al.. (2015). Improving Detection of IV Infiltrates in Neonates. BMJ Quality Improvement Reports. 4(1). u204253.w3874–u204253.w3874. 11 indexed citations
8.
DeMichele, Angela, Amy S. Clark, Kay See Tan, et al.. (2014). CDK 4/6 Inhibitor Palbociclib (PD0332991) in Rb+ Advanced Breast Cancer: Phase II Activity, Safety, and Predictive Biomarker Assessment. Clinical Cancer Research. 21(5). 995–1001. 280 indexed citations
9.
Clark, Amy S., Peter J. O’Dwyer, Daniel F. Heitjan, et al.. (2014). A phase I trial of palbociclib and paclitaxel in metastatic breast cancer.. Journal of Clinical Oncology. 32(15_suppl). 527–527. 16 indexed citations
10.
Langer, Melissa, E. Kubista, M. Schemper, & J. Spona. (1990). Androgen receptors, serum androgen levels and survival of breast cancer patients. Archives of Gynecology and Obstetrics. 247(4). 203–209. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026